2025 Biomedical Cross-Border Cooperation Forum
2025-11-13 19:34:55

2025 Biomedical Cross-Border Cooperation Forum

The "2025 Biomedical Cross-Border Cooperation Forum" was held as a parallel event of the China International Fair for Investment and Trade (CIFIT). International pharmaceutical enterprises such as Eli Lilly and Pfizer, as well as 25 domestic innovative pharmaceutical enterprises, were invited to participate. The White Paper on Global Biopharmaceutical Production Capacity Cooperation was released, and 4 domestic pharmaceutical enterprises were facilitated to reach API (Active Pharmaceutical Ingredient) contract manufacturing cooperation with European enterprises. It is expected to generate an additional annual output value of 300 million yuan.